MPD-RC 112 trial of pegylated interferon alpha-2a for polycythemia vera & essential thrombocythemia
Amyloidosis: patient fitness determines therapeutic strategies
How can pregnancy in myeloproliferative neoplasms (MPNs) be managed?
MAJIC trial results: ruxolitinib compared to best available therapy for essential thrombocythemia
Patient and physician perceptions on the symptomatic and economic burden of MPNs